Independent healthcare equity research
Biology first.
Market-aware by design.
A personal research archive on U.S. biotech companies where clinical evidence, regulatory timing, cash runway and market expectations meet.
Research date18 Jul 2026
Coverage5 companies + 1 thematic report
Core questionWhat is real, and what is already priced?
Current coverage
Research notes, one thesis at a time.
Click any row to enter a dedicated report page. Company discussion signals reflect a recent public Reddit scan only; they are not investment scores.
Research workflow
Two inputs. Two parallel lines. One research view.
This visual adapts the workflow in the supplied guide for biotech: a fundamental line and an event/sentiment line must both be visible before the final note is written.
For clinical-stage biotech, the “fundamental” line explicitly includes trial design, safety, regulatory path and cash runway. The “sentiment” line helps frame expectations and catalysts; it never substitutes for evidence.